FDA Approves First Cream for Treating Chronic Hand Eczema

FDA Approves First Cream for Treating Chronic Hand Eczema

FDA approves first cream for treating chronic hand eczema

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE).

Anzupgo FDA Approved as First Treatment Meant for Chronic Hand Eczema in Adults

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

FDA Approves Delgocitinib for Moderate to Severe Hand Eczema

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are contraindicated stand to benefit the most from this approval.

Delgocitinib Cream Approved as First Treatment for Moderate-to-Severe Chronic Hand Eczema in the US

Delgocitinib cream has received approval as the first a […] The post Delgocitinib Cream Approved as First Treatment for Moderate-to-Severe Chronic Hand Eczema in the US first appeared on GeneOnline News. The post Delgocitinib Cream Approved as First Treatment for Moderate-to-Severe Chronic Hand Eczema in the US appeared first on GeneOnline News.

Delgocitinib Approved by FDA for Chronic Hand Eczema

The topical JAK inhibitor is the first treatment approved specifically for adults with moderate-to-severe chronic hand eczema.